Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Operating Income (2016 - 2025)

Medicure has reported Operating Income over the past 17 years, most recently at $55215.6 for Q4 2025.

  • For Q4 2025, Operating Income rose 115.43% year-over-year to $55215.6; the TTM value through Dec 2025 reached -$259763.2, down 102.68%, while the annual FY2025 figure was -$4.9 million, 152.1% down from the prior year.
  • Operating Income for Q4 2025 was $55215.6 at Medicure, down from $645978.5 in the prior quarter.
  • Over five years, Operating Income peaked at $10.9 million in Q2 2024 and troughed at -$848142.8 in Q3 2024.
  • A 5-year average of $833665.2 and a median of $155657.8 in 2023 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: surged 4372.39% in 2024 and later plummeted 1718.71% in 2025.
  • Year by year, Operating Income stood at $261007.6 in 2021, then grew by 21.37% to $316782.3 in 2022, then fell by 7.95% to $291610.6 in 2023, then crashed by 222.74% to -$357924.6 in 2024, then skyrocketed by 115.43% to $55215.6 in 2025.
  • Business Quant data shows Operating Income for MCUJF at $55215.6 in Q4 2025, $645978.5 in Q3 2025, and -$504477.0 in Q2 2025.